JENSEN BIOCONSULT ApS: Financial statements 2019
CVR: 35670491
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
JENSEN BIOCONSULT ApS (CVR 35670491) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 5,505 and a net result of DKK 5,060 compared with DKK 4,555 the year before. That is an increase of 20.9% compared with the year before. Equity in the 2019 report amounted to DKK 43,478. The solvency ratio was 29.6%.
- Gross Profit
- DKK 5,505
- Profit/Loss
- DKK 5,060
- Equity
- DKK 43,478
- Total Assets
- DKK 146,723
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | 6 t. | 5 t. | 43 t. | - |
| 2018 | - | 5 t. | 5 t. | 38 t. | - |
| 2017 | - | -4 t. | -6 t. | 34 t. | - |
| 2016 | - | -7 t. | -6 t. | 39 t. | - |
| 2015 | 45 t. | 38 t. | 29 t. | 46 t. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
JENSEN BIOCONSULT ApS has published its annual report for 2018. Gross profit came to DKK 4,555, and the net result was DKK 4,555.
About JENSEN BIOCONSULT ApS
JENSEN BIOCONSULT ApS is a Danish company of the type Anpartsselskab based in Stenløse, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named JENSEN BIOCONSULT IVS. The management consists of Simon Skjøde Jensen. The company is owned by Simon Skjøde Jensen. The company has 0 employees (2014). In 2025, the company reported a gross profit of DKK -4,120 and a net result of DKK -32,288 compared with DKK -24,690 the year before. Equity in the 2025 report amounted to DKK -71,674.